{"id":"https://openalex.org/W2018493264","doi":"https://doi.org/10.1016/s0960-894x(96)00552-5","title":"Lipophilic bis-arylsulfonates as inhibitors of the CD4-gp120 interaction","display_name":"Lipophilic bis-arylsulfonates as inhibitors of the CD4-gp120 interaction","publication_year":1996,"publication_date":"1996-12-01","ids":{"openalex":"https://openalex.org/W2018493264","doi":"https://doi.org/10.1016/s0960-894x(96)00552-5","mag":"2018493264"},"language":"en","primary_location":{"id":"doi:10.1016/s0960-894x(96)00552-5","doi":"https://doi.org/10.1016/s0960-894x(96)00552-5","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0960-894x(96)00552-5","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056693530","display_name":"Raymond J. Patch","orcid":"https://orcid.org/0000-0003-0561-0038","observed_orcids":["https://orcid.org/0000-0003-0561-0038"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raymond J. Patch","raw_affiliation_strings":["Department of Rational Drug Design Procept, Inc., 840 Memorial Drive, Cambridge, Massachusetts, 02139 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rational Drug Design Procept, Inc., 840 Memorial Drive, Cambridge, Massachusetts, 02139 USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058574189","display_name":"John C Q Roberts","orcid":"https://orcid.org/0000-0002-0059-430X","observed_orcids":["https://orcid.org/0000-0002-0059-430X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John C. Roberts","raw_affiliation_strings":["Department of Rational Drug Design Procept, Inc., 840 Memorial Drive, Cambridge, Massachusetts, 02139 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rational Drug Design Procept, Inc., 840 Memorial Drive, Cambridge, Massachusetts, 02139 USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007054196","display_name":"Huai Gao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Huai Gao","raw_affiliation_strings":["Department of Rational Drug Design Procept, Inc., 840 Memorial Drive, Cambridge, Massachusetts, 02139 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rational Drug Design Procept, Inc., 840 Memorial Drive, Cambridge, Massachusetts, 02139 USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101794232","display_name":"Zhan Shi","orcid":"https://orcid.org/0000-0002-5970-9271","observed_orcids":["https://orcid.org/0000-0002-5970-9271"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhan Shi","raw_affiliation_strings":["Department of Rational Drug Design Procept, Inc., 840 Memorial Drive, Cambridge, Massachusetts, 02139 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rational Drug Design Procept, Inc., 840 Memorial Drive, Cambridge, Massachusetts, 02139 USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047829660","display_name":"Ariamala Gopalsamy","orcid":"https://orcid.org/0000-0003-3704-3891","observed_orcids":["https://orcid.org/0000-0003-3704-3891"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ariamala Gopalsamy","raw_affiliation_strings":["Department of Rational Drug Design Procept, Inc., 840 Memorial Drive, Cambridge, Massachusetts, 02139 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rational Drug Design Procept, Inc., 840 Memorial Drive, Cambridge, Massachusetts, 02139 USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086363753","display_name":"Azis Kongsjahju","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Azis Kongsjahju","raw_affiliation_strings":["Department of Rational Drug Design Procept, Inc., 840 Memorial Drive, Cambridge, Massachusetts, 02139 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rational Drug Design Procept, Inc., 840 Memorial Drive, Cambridge, Massachusetts, 02139 USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kevin Daniels","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kevin Daniels","raw_affiliation_strings":["Department of Rational Drug Design Procept, Inc., 840 Memorial Drive, Cambridge, Massachusetts, 02139 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rational Drug Design Procept, Inc., 840 Memorial Drive, Cambridge, Massachusetts, 02139 USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075709816","display_name":"Paul Kowalczyk","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul J. Kowalczyk","raw_affiliation_strings":["Department of Rational Drug Design Procept, Inc., 840 Memorial Drive, Cambridge, Massachusetts, 02139 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rational Drug Design Procept, Inc., 840 Memorial Drive, Cambridge, Massachusetts, 02139 USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075038162","display_name":"Marie-Rose van Schravendijk","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marie-Rose van Schravendijk","raw_affiliation_strings":["Department of Protein Biochemistry Procept, Inc., 840 Memorial Drive, Cambridge, Massachusetts, 02139 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Protein Biochemistry Procept, Inc., 840 Memorial Drive, Cambridge, Massachusetts, 02139 USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070272464","display_name":"Kristin A. Gordon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kristin A. Gordon","raw_affiliation_strings":["Department of Immunology, Procept, Inc., 840 Memorial Drive, Cambridge, Massachusetts, 02139 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Immunology, Procept, Inc., 840 Memorial Drive, Cambridge, Massachusetts, 02139 USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089806964","display_name":"Peter V. Pallai","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter V. Pallai","raw_affiliation_strings":["Department of Rational Drug Design Procept, Inc., 840 Memorial Drive, Cambridge, Massachusetts, 02139 USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rational Drug Design Procept, Inc., 840 Memorial Drive, Cambridge, Massachusetts, 02139 USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3880,"currency":"USD","value_usd":3880},"apc_paid":null,"fwci":0.9562,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.75669759,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"6","issue":"24","first_page":"2983","last_page":"2988"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.7372999787330627,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.7372999787330627,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.09279999881982803,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10835","display_name":"Carbohydrate Chemistry and Synthesis","score":0.03869999945163727,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lipophilicity","display_name":"lipophilicity","score":0.7450000047683716},{"id":"https://openalex.org/keywords/hiv-1-envelope-glycoprotein","display_name":"HIV-1 envelope glycoprotein","score":0.7990000247955322},{"id":"https://openalex.org/keywords/hiv-1-entry-inhibitors","display_name":"HIV-1 entry inhibitors","score":0.5590000152587891},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8949999809265137},{"id":"https://openalex.org/keywords/antiretroviral-drug-design","display_name":"antiretroviral drug design","score":0.6230000257492065}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9529350996017456},{"id":"https://openalex.org/C201399114","wikidata":"https://www.wikidata.org/wiki/Q898401","display_name":"Lipophilicity","level":2,"score":0.9272255897521973},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.6811054944992065},{"id":"https://openalex.org/C57992300","wikidata":"https://www.wikidata.org/wiki/Q2066956","display_name":"Potency","level":3,"score":0.649448573589325},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.6004437208175659},{"id":"https://openalex.org/C2992453875","wikidata":"https://www.wikidata.org/wiki/Q2270","display_name":"Benzene derivatives","level":4,"score":0.41339829564094543},{"id":"https://openalex.org/C114373084","wikidata":"https://www.wikidata.org/wiki/Q273499","display_name":"Chemical synthesis","level":3,"score":0.3852940499782562},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.33600372076034546},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3134082853794098}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s0960-894x(96)00552-5","doi":"https://doi.org/10.1016/s0960-894x(96)00552-5","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0960-894x(96)00552-5","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.6240000128746033,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1897990157","https://openalex.org/W1981164507","https://openalex.org/W1984360837","https://openalex.org/W1987293364","https://openalex.org/W1988839199","https://openalex.org/W1989749109","https://openalex.org/W2030882545","https://openalex.org/W2051593410","https://openalex.org/W2075790312","https://openalex.org/W2083556128","https://openalex.org/W2097305591","https://openalex.org/W2113282092","https://openalex.org/W2115808507","https://openalex.org/W2158988444","https://openalex.org/W2225285240","https://openalex.org/W2491560325"],"related_works":["https://openalex.org/W2016347738","https://openalex.org/W2949318433","https://openalex.org/W2951190374","https://openalex.org/W4214930706","https://openalex.org/W2060848806","https://openalex.org/W2030631228","https://openalex.org/W1982680718","https://openalex.org/W2093886700","https://openalex.org/W1988066220","https://openalex.org/W2972278470"],"abstract_inverted_index":null,"counts_by_year":[{"year":2019,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2016-06-24T00:00:00"}